Member Info for Saxondale

Just out of curiosity , I googled the contact name on the Texas trial site : Sukeshi Patel Arora

Turns out she is a very well regared doctor , specialising in Liver Cancer ( hepatocellular carcinoma) which is one of the cohorts of the Clevegen program .
She and her team were recognised in 2019 for their efforts with a Clinical Investigator of the Year award .

So a perfect choice for one arm of the next phase trials .

The article below highlights how a potential treatment for liver cancer would be even more relevant in Southern Texas -
'Because HCC is so prevalent in our patient population here, we are able to offer patients access to new drugs through clinical trials,” she said. “While it is not a common cancer, it is more prevalent here than in other parts of the country'

https://magazines.uthscsa.edu/cancer-center/2020/06/15/2019-clinical-investigator-of-the-year/

Oldish news , but I finally worked out how to compare the Clinical Trial details when a change is made , to see what the change has been .
The Clevegen trial data was updated on 25th Aug this year , and nothing seemed to have changed .
But if you scroll to the bottom of the page , you can click on a tab that shows any recent changes .

So , whether it is of any relevance or not , who knows , but on 25th Aug , there were two additional study sites added to the trial - Texas , USA and France.

Texas seemed the most interesting , as here we have for the first time , a study hospital in America .

It wasn't long after this that we had the Hibiscus trial details and the tie in with Stanford and Harvard with Traumakine .

Anyway , nothing major , but it confirms what I thought about them making more connections over in the biggest market in the world for drugs .
And don't forget , we have Dr Derek Angus over at the University of Pittsburgh - who is running the only stateside arm of the REMAP -CAP trial - with our IFN Beta1a in its own trial .
1234 patients now taking part in REMAP who have Covid , 1899 altogether .
Faron got involved early May - so the topline data from that trial is also overdue .
Details of change :

https://clinicaltrials.gov/ct2/show/NCT03733990?term=faron&draw=2&rank=1

United States, Texas
The University of Texas Health Science Center at San Antonio
[Recruiting]
San Antonio, Texas, United States, 78229-3901
Contact: Sukeshi Patel Arora, MD, PhD

France
The Institut Gustave Roussy
[Recruiting]
Villejuif, France, 94805
Contact: Christophe Massard, MD, PhD

I'd concur with that Shear .
Start the day with that massive pre opening hike , to look like someone knows something , and its a great buy .
Take it up to record highs and sit there for an hour or two , until the people who think it may go higher start to get impatient and have a few doubts . They start seeing how much they've made over the last week and think , maybe thats it .
Then have a mini crash , and start the slow downhill roll , picking off the sellers through the day as the shine is wiped off the SP , giving the impression that its all been a bit overhyped this week , and needs a reset .
Well , mission accomplished for them - millions of shares changed hands .
Myself , I just added a few more thanks

On the Bourse trading page , i am now getting adverts for luxury helicopter charters . Is this targeted advertising to the average NCYT holder now perhaps ?

So obvious what that was .
Well done to anyone who managed to buy in again

Faron are presenting at a couple of conferences this month .
Bio Europe - partnering conference 26-29th Oct
https://informaconnect.com/bioeurope/
and
Macrophage-directed Therapies summit 27-29 Oct

Nice to see Juho Jalkanen pictured front and middle of the media blurb .

https://macrophage-directed-therapies.com/program/full-event-guide/

This is a conference specializing in Cancer Immunology , so you'd think Faron would like to bring some new information to this - and updates , not just run the old slides again .

9.00am Registration and Coffee - so considering its a completely digital event for 2020 , I presume that means everyone just puts their kettle on lol .

Well i'm being offered 35.2p for all mine - no chance

On the Clevegen tab - you now see this

I noted one of the reasons why they were selected - future drivers of economic growth for Europe

EIC Accelerator project MAGIF

In June 2020 Faron was selected to receive a €2.5 million grant from the European Innovation Council (EIC) Accelerator pilot scheme. Release 11 Jun 2020

Faron's EIC Accelerator funded project MAGIF “Faron leading the way in macrophage guided immunotherapy” is focused on progressing the MATINS study and related business activities. The 2-year project period began on 1st October 2020 following the signing of the Grant Agreement.

About the EIC Accelerator pilot scheme

The EIC Accelerator pilot scheme supports top-class innovators, entrepreneurs, small companies and scientists with funding opportunities to support developing and bringing to the market new breakthrough products, services and business models that would become future drivers of economic growth for Europe. EIC Accelerator

About the MATINS study

The ongoing phase I/II MATINS clinical trial is investigating the tolerability, safety and efficacy of Clevegen, the Company's wholly-owned novel precision cancer immunotherapy targeting Clever-1 positive tumour associated macrophages (TAM), in selected metastatic or inoperable solid tumours.

Been here in some form since the £1 days , so joined the train after it left the station , but have been enjoying the ride . Got off and sold at £5 odd , then bought back the next day as I just thought this has more legs ( mainly down to some of the great research and discussion shared here ) , added more again today .
So its never too late to get on the train .

The MM's will know that any potential top slicers will have been holding on for that last hours possible rise - so don't give in too easily . I'm going for a walk to avoid temptation :-)

If you fancy putting a few quid on a pharma that may blow any day ,keep an eye on FARN - pretty much ignored on LSE and not a day traders share .
Finland have a sleeping giant .
Two big shots at goal coming up .

JT you need to change your report to - Captains log

Good spot Oil , reminds me of when I posted up a Lancet review and then it turns up a few days later in an RNS.
I just hope they aren't relying on me and you to spot things for them lol !

The fact that this is not the first phase 3 trial that they are doing , means they have learnt so many lessons .
INTEREST was a BIG trial , followed up by YODA to confirm their findings .
They know the way Traumakine works and is effective , and also how and when it isn't .

This knowledge will pay off dividends to them when making their analysis of Solidarity and Remap data , as they will know what data to look for , and what explains it .

Got in at about 2.7p
Sold half my holding at 5p 2 days before suspension - thought i was the kiddy lol

Bought it all back and more at 11p , 5 months later
Added more at 17p
Not sold a bean since

maybe a pumpkin & dumpkin ?

Lettuce hope an RNS turnips soon

Thanks Halti .
Interesting to note they now have over 7000 shareholders in Finland .
They had 200 before listing on the nasdaq - so that is exceptional .
Looks like the country has taken Faron to its heart .
Hopefully they will be very proud of whats to come

Well thats popped my original sale guess( 31p)
With flaps deployed , we will now hopefully sail up to my new target ( £1.55)
Rum is sitting in the cabinet ready , although the Morrisons delivery guy left it with the antitheft thing stuck on it , so looks like I have to smash the thing open like the Queen mum launching a ship !

Slightly odd project to undertake ?
So they basically googled everything - and came to the conclusion that the trials are hard to implement , and have failed to deliver conclusions before the end of the pandemic .
No Sh*t Sherlock . I would imagine setting up a trial worldwide during a pandemic is certainly hard to implement , and rushing to conclusions to appease public appetite is a wholly dangerous and unscientific way to do things .
Sounds a bit like sour grapes to me .

sorry thought it was a new one - it was the one we've all seen ( ive now seen it twice lol )